A treatment used for COPD has been found effective and safe for children ages one through five whose asthma is not controlled by other medications in a new clinical trial. This is consistent with the findings for the drug among older children and adults.
Is your child's asthma successfully managed by treatments already on the market?
“Recent studies in children and adolescents between 6 and 18 show that tiotropium add-on therapy has a safety and tolerability profile comparable with placebo, irrespective of asthma severity,” Vrijlandt said. “Our small study is the first to assess the safety and efficacy of tiotropium in children aged 1-5 years with persistent asthma symptoms.”